-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Academician Hejie published an article titled "Cancer Incidence and Mortality in China, 2016" at JNCC as the corresponding author
.
Based on the latest data from the National Cancer Center, the study selected 487 high-quality surveillance sites from 682 cancer surveillance sites across the country, covering a population of 380 million, and elaborated on the cancer disease burden in China in 2016
Compared with 2015, the number of monitoring sites that reported statistical data increased by 181, and the number of high-quality monitoring sites increased by 119, indicating that the coverage of tumor registration in China has gradually advanced, and the quality and standardization of data have been further improved, providing better support for national health policy formulation.
strong scientific basis
.
basic situation
basic situationNew cases: 4.
064 million
064 million
World standard occurrence rate: 1.
8646/100,000
Men are higher than women (207.
03/100,000 vs 1.
6814/100,000)
03/100,000 vs 1.
6814/100,000)
gender difference
gender difference gender difference
age difference
age difference age differenceMen are higher than women: 0~19 years old, 60 years old and above
Women are higher than men: 15-59 years old
Peak: The peak of new cancer cases in both men and women is between 60 and 79 years old
regional difference
regional differences regional differencesOverall urban higher than rural (1.
897/100,000 vs 1.
762/100,000)
Cities are higher than rural areas: lung cancer , breast cancer ,Colorectal cancer , prostate cancer
Cities are higher than rural areas: lung cancer , breast cancer ,Colorectal cancer , prostate cancer, lung cancer, breast cancercolorectal cancerRural areas are higher than cities:Gastric cancer , liver cancer, cervical cancer, esophageal cancer
Rural areas are higher than cities:Gastric cancer , liver cancer, cervical cancer, esophageal cancerstomach cancerCancer deaths in my country in 2016
Cancer deaths in China in 2016 Cancer deaths in China in 2016basic situation
Total deaths: 2.
414 million
414 million
World Standard Death Rate: 105.
19/100,000
Men outnumber women (138.
14/100,000 vs 73.
95/100,000)
gender difference
gender difference gender differenceAll age groups: Men die more than women
Men die more than womenDeath rate for women is higher than for men: gallbladder cancer, thyroid cancer
Gallbladder cancer, Thyroid cancerMortality in men is higher than in women: all other cancers
All other cancers
age difference
age difference age differenceMen are higher than women: 0~14 years old, 60 years old and above
Women are higher than men: 15-59 years old
Highest mortality rate: 60-79 years old
regional difference
regional differences regional differencesOverall rural higher than urban (106.
1/100,000 vs 102.
8/100,000)
Urban higher than rural: lung, colorectal, breast, prostate cancer
Lung, colorectal, breast, prostate cancerRural areas are higher than urban areas: liver cancer, stomach cancer, esophageal cancer, cervical cancer
Liver cancer, stomach cancer, esophageal cancer, cervical cancerTrends of cancer incidence and mortality in China from 2000 to 2016
Trends of Cancer Incidence and Mortality in China from 2000 to 2016 Trends of Cancer Incidence and Mortality in China from 2000 to 2016Incidence trend
Incidence trendrise:
-
Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer
-
Women: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer
Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer
Men: Prostate cancer, colorectal cancer, leukemia , brain tumor, pancreatic cancer , and bladder cancer
Prostate, Colorectal, Leukemia , Brain Tumors, Pancreatic and Bladder Cancers Leukemia Pancreatic CancerWomen: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer
Women: Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancer
Thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumor, lung cancer, colorectal cancerdecline:
-
Men and women: esophagus, stomach, liver cancer
Men and women: esophagus, stomach, liver cancer
Men and women: esophagus, stomach, liver cancer
Mortality Trend
Mortality Trendrise:
-
Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia
-
Women: Cervical cancer, thyroid cancer, breast cancer
Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia
Men: Prostate cancer, colorectal cancer, pancreatic cancer, leukemia
Prostate cancer, colorectal cancer, pancreatic cancer, leukemiaWomen: Cervical cancer, thyroid cancer, breast cancer
Women: Cervical cancer, thyroid cancer, breast cancer
Cervical cancer, thyroid cancer, breast cancerdecline:
-
Men and women: esophagus, stomach, liver, lung
Men and women: esophagus, stomach, liver, lung
Men and women: esophagus, stomach, liver, lung
Trends in incidence and mortality of selected cancers in men and women from 2000 to 2016
.
A: male incidence; B: female incidence; C: male mortality; D: female mortality
summary summary
incidence
incidence-
The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;
-
The first incidence: lung cancer in men and breast cancer in women;
-
The incidence rate is higher in cities than in rural areas;
-
The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;
-
The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim
The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;
The overall crude incidence of cancer in my country continues to rise, reflecting the actual burden of cancer in my country;
The first incidence: lung cancer in men and breast cancer in women;
The first incidence: lung cancer in men and breast cancer in women;
The incidence rate is higher in cities than in rural areas;
The incidence rate is higher in cities than in rural areas;
The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;
The traditional high incidence of esophageal cancer, gastric cancer, liver cancer and other tumors in China shows a continuous downward trend, but the disease burden is still heavy;
The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim
The incidence of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries is showing a continuous upward trend, and the prevention and control situation is grim
mortality rate
mortality rate-
The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;
-
Leading death: Lung cancer in both men and women;
-
Mortality rates in rural areas are higher than in urban areas;
-
The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;
-
The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend
The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;
The crude cancer mortality rate in my country is still on the rise, but after adjusting the age structure of the population, the standardized mortality rate shows a downward trend, reflecting the preliminary results of comprehensive cancer prevention and control in my country in recent years;
Leading death: Lung cancer in both men and women;
Leading death: Lung cancer in both men and women;
Mortality rates in rural areas are higher than in urban areas;
Mortality rates in rural areas are higher than in urban areas;
The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;
The mortality rate of esophageal cancer, gastric cancer, liver cancer and other tumors with high incidence and poor prognosis in my country is decreasing year by year, but the mortality rate of cervical cancer is still on the rise;
The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend
The mortality rates of colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors with high incidence in developed countries show a continuous upward trend
Original source:
Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, Li L, Wei WQ, He J.
leave a message here